COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?

The authors present the data on the potential of the combination of angiotensin-converting enzyme inhibitors and calcium channel antagonists in the treatment of hypertensive patients with chronic heart failure and preserved left ventricular ejection fraction. The informed choice of lisinopril, as a...

Full description

Bibliographic Details
Main Authors:	I. V. Zhirov, O. A. Nikolaeva, S. N. Tereshchenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2013-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	angiotensin-converting enzyme inhibitor lisinopril amlodipine chronic heart failure with preserved left ventricular systolic function
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/97

id	doaj-e7217fbd56cf44ec856591a0bf63afdc
record_format	Article
spelling	doaj-e7217fbd56cf44ec856591a0bf63afdc2021-07-28T13:50:57Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-12-01126293310.15829/1728-8800-2013-6-29-3397COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?I. V. Zhirov0O. A. Nikolaeva1S. N. Tereshchenko2A.L. Myasnikov Research Institute of Cardiology, Russian Cardiology Scientific and Clinical Complex, MoscowA.L. Myasnikov Research Institute of Cardiology, Russian Cardiology Scientific and Clinical Complex, MoscowA.L. Myasnikov Research Institute of Cardiology, Russian Cardiology Scientific and Clinical Complex, MoscowThe authors present the data on the potential of the combination of angiotensin-converting enzyme inhibitors and calcium channel antagonists in the treatment of hypertensive patients with chronic heart failure and preserved left ventricular ejection fraction. The informed choice of lisinopril, as a component of such a combination, is justified.https://cardiovascular.elpub.ru/jour/article/view/97angiotensin-converting enzyme inhibitorlisinoprilamlodipinechronic heart failure with preserved left ventricular systolic function
collection	DOAJ
language	Russian
format	Article
sources	DOAJ
author	I. V. Zhirov O. A. Nikolaeva S. N. Tereshchenko
spellingShingle	I. V. Zhirov O. A. Nikolaeva S. N. Tereshchenko COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE? Кардиоваскулярная терапия и профилактика angiotensin-converting enzyme inhibitor lisinopril amlodipine chronic heart failure with preserved left ventricular systolic function
author_facet	I. V. Zhirov O. A. Nikolaeva S. N. Tereshchenko
author_sort	I. V. Zhirov
title	COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_short	COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_full	COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_fullStr	COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_full_unstemmed	COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_sort	combination of angiotensin-converting enzyme inhibitors and calcium channel blockers in hypertensive patients with heart failure and preserved systolic function: is there a place for an informed choice?
publisher	«SILICEA-POLIGRAF» LLC
series	Кардиоваскулярная терапия и профилактика
issn	1728-8800 2619-0125
publishDate	2013-12-01
description	The authors present the data on the potential of the combination of angiotensin-converting enzyme inhibitors and calcium channel antagonists in the treatment of hypertensive patients with chronic heart failure and preserved left ventricular ejection fraction. The informed choice of lisinopril, as a component of such a combination, is justified.
topic	angiotensin-converting enzyme inhibitor lisinopril amlodipine chronic heart failure with preserved left ventricular systolic function
url	https://cardiovascular.elpub.ru/jour/article/view/97
work_keys_str_mv	AT ivzhirov combinationofangiotensinconvertingenzymeinhibitorsandcalciumchannelblockersinhypertensivepatientswithheartfailureandpreservedsystolicfunctionisthereaplaceforaninformedchoice AT oanikolaeva combinationofangiotensinconvertingenzymeinhibitorsandcalciumchannelblockersinhypertensivepatientswithheartfailureandpreservedsystolicfunctionisthereaplaceforaninformedchoice AT sntereshchenko combinationofangiotensinconvertingenzymeinhibitorsandcalciumchannelblockersinhypertensivepatientswithheartfailureandpreservedsystolicfunctionisthereaplaceforaninformedchoice
_version_	1721271063563730944

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?

Similar Items